Literature DB >> 25044447

Soluble CD163 is associated with noninvasive measures of liver fibrosis in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected women.

Mark H Kuniholm1, David B Hanna, Alan L Landay, Robert C Kaplan, Klaus Ley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25044447      PMCID： PMC4291302          DOI： 10.1002/hep.27303

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

2.  Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.

Authors:  Iftach Shaked; David B Hanna; Christian Gleißner; Brenda Marsh; Jill Plants; Daniel Tracy; Kathryn Anastos; Mardge Cohen; Elizabeth T Golub; Roksana Karim; Jason Lazar; Vinayaka Prasad; Phyllis C Tien; Mary A Young; Alan L Landay; Robert C Kaplan; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-20       Impact factor: 8.311

3.  Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

Authors:  Konstantin Kazankov; Francisco Barrera; Holger Jon Møller; Bo Martin Bibby; Hendrik Vilstrup; Jacob George; Henning Grønbaek
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425
  3 in total
  6 in total

1.  Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.

Authors:  Audrey L French; Jonathan W Martin; Charlesnika T Evans; Marion Peters; Seble G Kessaye; Marek Nowicki; Mark Kuniholm; Elizabeth Golub; Michael Augenbraun; Seema N Desai
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

2.  Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.

Authors:  Anna Lidofsky; Jacinta A Holmes; Eoin R Feeney; Annie J Kruger; Shadi Salloum; Hui Zheng; Isabel S Seguin; Akif Altinbas; Ricard Masia; Kathleen E Corey; Jenna L Gustafson; Esperance A Schaefer; Peter W Hunt; Steven Deeks; Ma Somsouk; Kara W Chew; Raymond T Chung; Nadia Alatrakchi
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

3.  Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.

Authors:  David B Hanna; Juan Lin; Wendy S Post; Howard N Hodis; Xiaonan Xue; Kathryn Anastos; Mardge H Cohen; Stephen J Gange; Sabina A Haberlen; Sonya L Heath; Jason M Lazar; Chenglong Liu; Wendy J Mack; Igho Ofotokun; Frank J Palella; Phyllis C Tien; Mallory D Witt; Alan L Landay; Lawrence A Kingsley; Russell P Tracy; Robert C Kaplan
Journal:  J Infect Dis       Date:  2017-05-01       Impact factor: 7.759

Review 4.  Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation.

Authors:  Lenche Kostadinova; Carey L Shive; Donald D Anthony
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

5.  Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection.

Authors:  Rongrong Yang; Xien Gui; Hengning Ke; Yong Xiong; Shicheng Gao
Journal:  AIDS Res Ther       Date:  2021-12-19       Impact factor: 2.250

6.  Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.

Authors:  Jessica L Mueller; Eoin R Feeney; Hui Zheng; Joseph Misdraji; Annie J Kruger; Nadia Alatrakchi; Lindsay Y King; Louis Gelrud; Kathleen E Corey; Raymond T Chung
Journal:  Clin Transl Gastroenterol       Date:  2015-10-08       Impact factor: 4.488
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.